NEW YORK (GenomeWeb News) – CombiMatrix on Tuesday reported a 15 percent increase in revenues for its third quarter, driven by an increase in diagnostic service revenues.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: epigenetic contributors to type 1 diabetes, assembly algorithm to detect structural variations, and more.
The Financial Times looks into how sequencing is moving into the clinic.
Mitochondrial replacement therapy may soon be occurring in the UK, according to the Guardian.
The US House of Representatives has passed the latest version of the 21st Century Cures Act.